ULURU Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2015
For the nine months, the company's revenues were $578,444 against $634,058 a year ago. The net decrease of $56,000 in revenues is attributable to a decrease of $17,000 in Altrazeal® product sales to international distributors and a decrease of $41,000 in royalties from the international distributors; which were partially offset by an increase of $2,000 in license fees related to Altrazeal®. Operating loss was $2,149,522 against $2,092,717 a year ago. Loss before income taxes was $2,333,742 compared to $2,256,865 a year ago. Net loss was $2,333,742 or $0.09 per share compared to $2,256,865 or $0.10 per share a year ago.